Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Signorini

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2021
ErratumLorenzo Signorini, Gianluigi Zaza, Giovanni Gambaro
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 6, 2020
The challenge of early glomerular filtration rate decline in response to antihypertensive treatment and chronic kidney disease outcomesLorenzo Signorini, Gianluigi Zaza, Giovanni Gambaro
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 2021
The challenge of early glomerular filtration rate decline in response to antihypertensive treatment and chronic kidney disease outcomesLorenzo Signorini, Gianluigi Zaza, Giovanni Gambaro
International Journal of Molecular Sciences|July 13, 2017
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney DiseaseLorenzo Signorini, Simona Granata, Antonio Lupo, et al.
Frontiers in Immunology|January 11, 2020
Effects of Antirejection Drugs on Innate Immune Cells After Kidney TransplantationGianluigi Zaza, Jeremy Leventhal, Lorenzo Signorini, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 3, 2017
Mechanisms underlying human genetic diversity: consequence for antigraft antibody responsesRoman Reindl-Schwaighofer, Andreas Heinzel, Lorenzo Signorini, et al.
Transplantation|January 26, 2018
mTOR Inhibition Role in Cellular MechanismsGianluigi Zaza, Simona Granata, Chiara Caletti, et al.
European Journal of Pharmacology|June 26, 2019
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapySimona Granata, Gloria Santoro, Lorenzo Signorini, et al.
Eclinicalmedicine|February 18, 2021
Corrigendum to "Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care" [EClinicalMedicine 28 (2020) 100,578]Paolo Fusar-Poli, Andrea De Micheli, Lorenzo Signorini, et al.
Schizophrenia Bulletin|April 19, 2020
Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort StudyPaolo Fusar-Poli, Andrea De Micheli, Rashmi Patel, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2021
ErratumLorenzo Signorini, Gianluigi Zaza, Giovanni Gambaro
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 6, 2020
The challenge of early glomerular filtration rate decline in response to antihypertensive treatment and chronic kidney disease outcomesLorenzo Signorini, Gianluigi Zaza, Giovanni Gambaro
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 2021
The challenge of early glomerular filtration rate decline in response to antihypertensive treatment and chronic kidney disease outcomesLorenzo Signorini, Gianluigi Zaza, Giovanni Gambaro
International Journal of Molecular Sciences|July 13, 2017
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney DiseaseLorenzo Signorini, Simona Granata, Antonio Lupo, et al.
Frontiers in Immunology|January 11, 2020
Effects of Antirejection Drugs on Innate Immune Cells After Kidney TransplantationGianluigi Zaza, Jeremy Leventhal, Lorenzo Signorini, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 3, 2017
Mechanisms underlying human genetic diversity: consequence for antigraft antibody responsesRoman Reindl-Schwaighofer, Andreas Heinzel, Lorenzo Signorini, et al.
Transplantation|January 26, 2018
mTOR Inhibition Role in Cellular MechanismsGianluigi Zaza, Simona Granata, Chiara Caletti, et al.
European Journal of Pharmacology|June 26, 2019
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapySimona Granata, Gloria Santoro, Lorenzo Signorini, et al.
Eclinicalmedicine|February 18, 2021
Corrigendum to "Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care" [EClinicalMedicine 28 (2020) 100,578]Paolo Fusar-Poli, Andrea De Micheli, Lorenzo Signorini, et al.
Schizophrenia Bulletin|April 19, 2020
Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort StudyPaolo Fusar-Poli, Andrea De Micheli, Rashmi Patel, et al.
Pageof 2